4,464 results match your criteria: "Boston Fox; Boston University School of Medicine[Affiliation]"
Br J Dermatol
October 2024
Department of Medicine, USC Keck School of Medicine, Los Angeles, CA, USA.
Transl Androl Urol
September 2024
Section of Urology, Dartmouth-Hitchock Medical Center, Lebanon, NH, USA.
Blood Cancer J
October 2024
Fox Chase Cancer Center, Philadelphia, PA, US.
Cancer Cell
January 2025
Department of Head and Neck Surgery and the Department of Genomic Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA; University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, Houston, TX, USA. Electronic address:
Cancer neuroscience is a rapidly growing multidisciplinary field that conceptualizes tumors as tissues fully integrated into the nervous system. Recognizing the complexity and challenges in this field is of fundamental importance to achieving the goal of translational impact for cancer patients. Our commentary highlights key scientific priorities, optimal training settings, and roadblocks to translating scientific findings to the clinic in this emerging field, aiming to formulate a transformative and cohesive path forward.
View Article and Find Full Text PDFPhys Rev Lett
October 2024
CERN, Geneva, Switzerland.
J Immigr Minor Health
October 2024
School of Nursing and Public Health, Moravian University, Bethlehem, PA, USA.
The lack of a cohesive, stakeholder-informed refugee health research agenda has been a barrier to promoting, funding, and conducting health research with refugee populations in North America. A cross-sectional study was conducted among individuals working in refugee health in North America (N = 93) to describe major domains within the field of refugee health research and to develop refugee health research priorities. Open-ended survey questions included: (1) What research topics specific to refugee research would you like to see in an international research agenda? (2) Please describe current and important gaps that you believe exist in refugee research and why? Overarching themes focused on the need for the development of research partnerships with refugee communities that are intentional, effective, and driven by the needs of refugee communities.
View Article and Find Full Text PDFNat Neurosci
December 2024
Montréal Neurological Institute, McGill University, Montréal, Quebec, Canada.
The brainstem is a fundamental component of the central nervous system, yet it is typically excluded from in vivo human brain mapping efforts, precluding a complete understanding of how the brainstem influences cortical function. In this study, we used high-resolution 7-Tesla functional magnetic resonance imaging to derive a functional connectome encompassing cortex and 58 brainstem nuclei spanning the midbrain, pons and medulla. We identified a compact set of integrative hubs in the brainstem with widespread connectivity with cerebral cortex.
View Article and Find Full Text PDFSci Transl Med
October 2024
Genetic Immunotherapy Section, Laboratory of Clinical Immunology and Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA.
Nat Neurosci
December 2024
Center for Translational & Computational Neuroimmunology, Department of Neurology, Columbia University Irving Medical Center, New York, NY, USA.
Human microglia play a pivotal role in neurological diseases, but we still have an incomplete understanding of microglial heterogeneity, which limits the development of targeted therapies directly modulating their state or function. Here, we use single-cell RNA sequencing to profile 215,680 live human microglia from 74 donors across diverse neurological diseases and CNS regions. We observe a central divide between oxidative and heterocyclic metabolism and identify microglial subsets associated with antigen presentation, motility and proliferation.
View Article and Find Full Text PDFCancer Epidemiol Biomarkers Prev
January 2025
Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, New York.
Blood Cancer J
October 2024
Fox Chase Cancer Center, Philadelphia, PA, US.
Lancet Child Adolesc Health
December 2024
Department of Radiology, LMU University Hospital, LMU Munich, Munich, Germany.
Background: Emerging evidence suggests that endovascular thrombectomy is beneficial for treatment of childhood stroke, but the safety and effectiveness of endovascular thrombectomy has not been compared with best medical treatment. We aimed to prospectively analyse functional outcomes of endovascular thrombectomy versus best medical treatment in children with intracranial arterial occlusion stroke.
Methods: In this prospective registry study, 45 centres in 12 countries across Asia and Australia, Europe, North America, and South America reported functional outcomes for children aged between 28 days and 18 years presenting with arterial ischaemic stroke caused by a large-vessel or medium-vessel occlusion who received either endovascular thrombectomy plus best medical practice or best medical treatment alone.
PLOS Glob Public Health
October 2024
Department of Global Health and Population, Harvard T.H. Chan School of Public Health, Harvard University, Boston, Massachusetts, United States of America.
Following the development of a vaccine for COVID-19, the expectation was instantaneous widespread distribution and uptake to halt further spread, severe illness and deaths from the virus. However, studies show very low uptake, especially in resource-poor settings, and little is documented about the drivers of vaccine uptake in populations classified as high-risk. In this study, we explored access and uptake of COVID-19 vaccines among people living with non-communicable diseases (PLWNCDs) in Ghana.
View Article and Find Full Text PDFBrain
December 2024
Department of Neurology, University Medical Center Hamburg-Eppendorf, Hamburg 20251Germany.
Neurol Clin Pract
February 2025
Edmond J. Safra Program in Parkinson's Disease and Morton and Gloria Shulman Movement Disorders Clinic (AB, AF), Toronto Western Hospital, UHN, Division of Neurology, University of Toronto; Krembil Brain Institute (AF); and Center for Advancing Neurotechnological Innovation to Application (CRANIA) (AF), Toronto, Ontario, Canada.
medRxiv
September 2024
"Aldo Ravelli" Center for Neurotechnology and Experimental Brain Therapeutics, Department of Health Sciences, University of Milan, Via Antonio di Rudinì 8, 20142 Milan, Italy.
ArXiv
October 2024
Chan Zuckerberg Initiative, Redwood City, CA, USA.
The cell is arguably the most fundamental unit of life and is central to understanding biology. Accurate modeling of cells is important for this understanding as well as for determining the root causes of disease. Recent advances in artificial intelligence (AI), combined with the ability to generate large-scale experimental data, present novel opportunities to model cells.
View Article and Find Full Text PDFJ Thorac Cardiovasc Surg
October 2024
Thoracic Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.
Ann Clin Transl Neurol
December 2024
Center for Brain Circuit Therapeutics, Department of Neurology, Psychiatry, and Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
J Cardiothorac Vasc Anesth
December 2024
Tufts Medical Center, Boston, MA.
Nature
November 2024
Department of Medicine, Weill Cornell Medicine, New York, NY, USA.
Nat Med
December 2024
F. Hoffmann-La Roche Ltd, Basel, Switzerland.
The Phase II trial of Anti-alpha-Synuclein Antibody in Early Parkinson's Disease (PASADENA) is an ongoing double-blind, placebo-controlled trial evaluating the safety and efficacy of prasinezumab in early-stage Parkinson's disease (PD). During the double-blind period, prasinezumab-treated individuals showed less progression of motor signs (Movement Disorders Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS) Part III) than placebo-treated individuals. We evaluated whether the effect of prasinezumab on motor progression, assessed as a change in MDS-UPDRS Part III score in the OFF and ON states, and MDS-UPDRS Part II score, was sustained for 4 years from the start of the trial.
View Article and Find Full Text PDFPediatr Rheumatol Online J
October 2024
Division of Immunology, Boston Children's Hospital and Harvard Medical School, 300 Longwood Ave, Fegan 6 Boston, Boston, MA, 02115, USA.
Nat Rev Neurol
December 2024
Division of Neurology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.
Am J Obstet Gynecol
October 2024
Department of Epidemiology, Boston University School of Public Health, Boston, MA.